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Lauren D. Arnold, PhD, MPH 
Sheri R. Notaro, PhD, MPH
Abstract: This study describes attitudes and social and environmental factors that affect 
African American parents’ intent to vaccinate their daughters against human papillomavirus 
(HPV). Thirty African American parents of daughters aged nine to 17 years and no his-
tory of HPV infection completed semi-structured interviews. Interviews addressed factors 
that influenced intent to vaccinate, perception of community norms related to vaccination, 
vaccination scenarios involving place of vaccination, and vaccination prior to or after the 
child’s initiation of sexual activity. A recurring theme was the influence of physician rec-
ommendation on African American parents’ intent to obtain HPV vaccination for their 
daughters. Most parents reported that they could overcome barriers to vaccination, except 
vaccine costs and lack of insurance. While religious beliefs were important to parents, they 
reported that they would not interfere with vaccination decisions; fears of early sexuality 
due to vaccination were limited. The implications of these findings are discussed.
Key words: African Americans, HPV vaccination, cultural attitudes and beliefs.
African American women experience higher cervical cancer incidence and mortality than their non-Hispanic White counterparts.1–3 The prevalence of human papil-
lomavirus (HPV) infection, which is associated with cervical cancer, is significantly 
higher in African American women as well.4 Although HPV vaccination can substantially 
lower the risk of cervical cancer, data indicate that less than 20% of eligible girls are fully 
vaccinated.5 Being African American has been correlated with both lower initiation and 
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lower completion of the HPV vaccine series.6,7 Given the higher cervical cancer burden 
in African Americans, understanding factors that affect HPV vaccination behaviors, 
including parental attitudes towards HPV vaccination of their daughters, is critical. 
Given that HPV vaccination is targeted at preadolescents or young adolescents, vac-
cine acceptability to parents is a central issue, and it is important to understand parental 
concerns and information needs. Studies also suggest that parental attitudes influence 
adolescent attitudes related to intent to receive the HPV vaccine.8–10 Constantine and 
Jerman completed a random digit dial household survey of parental intent to vaccinate 
in California.11 Data from this survey indicated that African American and Asian par-
ents were less likely than others to accept HPV vaccination.11 However, the number of 
African American participants was limited (n=36), which weakens confidence in the 
findings. Other studies have indicated greater skepticism among African American 
and Hispanic parents than among others.12,14,15 Many parents do not understand the 
rationale for the vaccine’s target age range and the implications of a vaccination decision 
for their children at any age.11–15 In addition, some parents have expressed concerns 
related to vaccine use and risky sexual behavior among adolescents, as well as mistrust 
of pharmaceutical companies promoting HPV vaccine use.11 While there are other 
studies of barriers to HPV vaccine use,16–18 results often are not reported separately for 
African Americans or other racial/ethnic minorities included in the samples. Finally, 
the studies that do report on African American parental concerns were conducted in 
Western or Southern states. Geographic variation in vaccination suggests a need to 
understand whether there are regional variations in parental attitudes that may affect 
HPV intent to vaccinate.19 
To address disparities in cancer incidence and mortality in an urban, Midwestern 
city, researchers from a Community Networks Program to Eliminate Cancer Dispari-
ties (PeCAD) conducted surveys and interviews to assess cervical cancer, HPV, and 
Pap smear knowledge among African American parents of females in the vaccination 
age range, as well as beliefs, attitudes, and structural barriers to HPV vaccination. An 
analysis of the interview data is presented in this paper. The primary aims of this project 
were to describe the cultural attitudes and social and environmental factors that affect 
African American parents’ intent to vaccinate. The use of individual interviews permits 
consideration of how the expression of religious, sexual, and health-related values, in 
addition to the influence of significant others, affect African American parents’ HPV 
decision making. This understanding can be useful in the consideration of education 
and intervention efforts. 
Methods
Participants. Study recruitment took place between February and June of 2009. Data 
presented here include the qualitative portion of a larger study of African American 
parents’ attitudes toward HPV vaccination. The parent study involved 200 African 
American men and women who completed a survey study, with a subset of 30 par-
ticipants selected for interview. The detailed methods used in the survey portion of 
the study are described in a separate paper.20 All participants were residents of the St. 
Louis Metropolitan Statistical Area. Eligibility criteria for the survey and the interview 
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were men and women who: 1) identified as African American, and 2) had a daughter 
nine to 17 years of age with no history of HPV infection.
Procedures. The Washington University in St. Louis’ Institutional Review Board 
approved this study and consent procedures. We used several sampling strategies. Com-
munity organizations, including a reproductive health service, father support center, 
and two health centers were primary recruitment sites. Each African American patron 
present during operational hours was approached to determine eligibility. This strategy 
resulted in 21 completed interviews. In addition, a community sampling strategy21 was 
used to diversify the sample and recruit individuals who did not participate in established 
organizations or seek health care from a usual source. Homes in ZIP codes containing 
more than 75% African Americans were approached to solicit eligible participants. Nine 
interview participants were recruited using this sampling strategy. 
Participants were approached by the African American principal investigator or one 
of two African American research assistants to complete a self-administered survey and 
received a $25.00 gift card for participation. The person soliciting survey participation 
also requested interview participation. Every third participant who received an odd 
identification number was asked to complete an interview, which took between 45 and 
60 minutes, until 30 participants (15% of the total sample) were interviewed. Refusal 
data were not recorded. Interviews were scheduled at participants’ convenience and 
completed at their preferred location. The majority of interviews were completed in 
participants’ homes (n19), with five completed in a private interview room at the 
recruitment site and six completed in an interview room at the investigator’s university.
All participants received a detailed explanation of the interview before providing 
consent and received an additional payment of $30. Interviews were audio-taped and 
transcribed verbatim. The transcripts were reviewed for accuracy by a research assistant, 
using the audiotape and field notes. 
interview protocol. Interview questions were developed by the first author based on 
a review of the existing literature and surveys found in the literature.16,22,23 The protocol 
used a problem-centered interview format, with a focus on HPV, HPV vaccine knowl-
edge, intent, and behavior, as well as facilitators and barriers to vaccination. Participants 
were asked to discuss their intent to have eligible children receive the vaccine, factors 
that influence intent or the decision to vaccinate (if a child received the vaccine), and 
their perception of community norms and concerns related to vaccination. Addition-
ally, they were asked to respond to materials that presented HPV vaccination in the 
context of sexual health vs. cancer prevention, vaccination scenarios involving loca-
tion of vaccination (private physician, community health clinic, health department, 
or facilities providing reproductive health services), and vaccination prior to or after 
the child’s initiation of sexual activity. Interviewers listened for themes and followed 
up on topics relevant to issues raised in prior interviews. Interviewers maintained the 
protocol, which provided prompts to permit interviewers to guide participants back 
to the central issue being explored, obtain greater details on topics raised, and obtain 
elaborations of ideas that seemed important. Field notes developed after each interview 
described the setting and any notable participant observations.24,25
Data analysis. The research team consisted of a psychologist and two graduate 
research assistants, who developed initial rules and categories for coding after review-
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ing project goals, the content of the interviews, and the existing literature. The coding 
scheme was revised as coding proceeded to include omitted categories and assure that 
interview content was accurately represented. There were three statement types coded: 
anecdotes, general attitudes or beliefs, and statements specific to HPV. The HPV-specific 
codes focused on positive or negative intent to vaccinate, attitudes related to vaccination 
encountered among physicians, family members, friends, and/or faith-based community 
members, statements specific to religious attitudes, youth sexuality, vaccine knowledge 
needs and safety, and barriers to vaccination. Additional coding captured statements 
related to preferences for receiving vaccine information and administration. 
Each interview was coded by two people. Each coder read and coded assigned tran-
scripts and then met with the partner to review codes and discuss any discrepancies 
until reaching consensus.24 Because coding was iterative, many discrepancies in early 
coding were related to the addition of new codes or to the elaboration of existing codes. 
The consensus approach was used to resolve these issues and the coding of earlier text 
was revised to reflect the new coding. If coders did not reach consensus, the principle 
investigator made the final coding decision based on a reading of the transcript text, 
review of coding rules, and available survey data. Once coding was complete, all three 
team members met to discuss core ideas and general themes. The discussions yielded 
a set of attitudes about HPV vaccination intent and the factors that influenced parents’ 
decisions, including community norms, HPV vaccination concerns, the role of beliefs 
about youth sexuality, and the role of religion and other barriers related to intent to 
vaccinate. These core findings were then refined and prioritized. The project’s com-
munity advisory council reviewed and provided comments on these findings. 
results
Interview participants included 25 women and five men, with an average age of 42.4 
years (range: 26–60). All interview participants reported that there was a usual place 
where they took a child for, or a usual person who provided, sick or routine care (e.g., 
private physician, federally qualified and community health clinics). Sixteen participants 
reported the use of private health insurance for their children, and another 10 parents 
reported that their daughters had some form of health insurance identified as Medicaid 
or State Children’s Health Insurance Program (SCHIP). Four parents indicated that 
they and their children were uninsured. The participant interviews offer insights into 
the factors that influence parental decisions about HPV vaccination. Six major themes 
were identified: the influence of physician recommendation, vaccine decision-making, 
desire for information related to vaccine safety, youth sexuality, HPV vaccine costs, 
and religious issues affecting HPV vaccination decisions. 
Physician recommendation. Physician recommendation was important in the 
decision to vaccinate due to interpersonal and professional factors. Most patients cited 
their trust of and long-term relationships with their child’s provider. In addition, several 
parents noted the importance of medical history in the decision to vaccinate and the 
ability of the physician to weigh the family and child’s health history when making a 
recommendation on HPV vaccination.
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Parent (P): Just because that’s who does all of her medical treatment. They know her 
medical history. They know her. So, I feel better with them providing her with any 
vaccinations or anything that she gets. 
P: Well, like I say, he’s been there since my kids been born. Plus he was my brother’s 
pediatrician. He’s [the brother], like 26 years old. He’s a family doctor you know. He’s 
been going down the line. So I really do trust him.
Parents gave examples of the rationales that physicians offered for their recommen-
dations, which included a history of chronic diseases such as sickle cell anemia and 
asthma. These parents indicated that the decision to vaccinate was to protect against 
infections that these chronically ill children would find more difficult to fight. Addi-
tionally, the child’s sexual activity or lack of sexual activity and vaccine safety were 
reportedly rationales for physician recommendation to vaccinate. 
P: Well, when she went for her physical, her pediatrician said that she wanted to wait 
for her to get the vaccination, because, I guess, the drug, or something with the vac-
cination hasn’t been FDA approved for at least five years. So she didn’t recommend 
her to get it just yet.
Participants in this sample were less concerned about their own knowledge because 
they felt that they could discuss these issues and obtain the necessary information from 
their providers. While parents noted that they lacked knowledge and were unlikely to 
vaccinate in the absence of a physician recommendation, there were limits on the role 
of the physician in the final decision to obtain HPV vaccination for their daughters. 
Parents went on to indicate that the final decision about vaccination was theirs. 
P: Her doctor was really pushing getting the vaccination. But I had to read up on it, 
get more information than I previously had. I try to impress upon my children the 
importance of being proactive about your own health. 
Vaccine decision-making. Men and women agreed that the final decision about 
HPV vaccination for their daughter’s was most often made by mothers, with father 
consultation as the mother thought necessary. 
P: I mean, because, you know, my husband leaves it up to me. My children, you know, 
it’s just I’ve always handled things. 
Most parents felt that the child could express feelings and concerns about vaccination, 
but ultimately the decision was made by the parent(s). 
P: She and her mother would discuss it and we’d [father and mother] just make a 
decision for her. 
P: Because at a certain age you do not be a part of decisions. I’d say when you at least 
18; you can decide. 
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Many reported that they felt obligated to inform their daughters about HPV, the vac-
cine and why they believed the vaccine was or was not beneficial. 
P: She was involved at the last minute. I gave her the pamphlet to read and talked to 
her you know. But other than that, no, I didn’t go into detail or anything.
P: I would give her some information about it. Letting her know why she would have 
to take it. I: “What if she didn’t want to take it?” P: I would find out why she wouldn’t 
take it. We would discuss the pros and cons to help her make an informed decision. 
Parents questioned the appropriateness of mandatory vaccination because of the 
likelihood of interfering with the parent’s decision making role, perceived differences 
in children’s risk of exposure to HPV, and possible religious objections. 
P: No I can’t say that I agree with that because I have a sister-in-law that Jehovah’s 
Witnesses and they don’t believe in a whole lot of stuff, so that they shouldn’t force 
it on people. 
P: Because if you feel that something is good for my child, that’s not really right [to 
make it mandatory]; because some vaccinations, I just feel it might not be necessary. 
Vaccine safety. In response to queries about barriers to vaccination, side-effects 
were most often cited. Many parents noted that they had seen very little information 
on the side-effects of youth HPV vaccination. 
P: Well, when I first heard about it, I said, Okay. But, what about the side effects? 
Because we haven’t really heard anything about the side effects.
When asked what side-effects would be of concern, they noted death, infertility, or risk 
of other diseases such as autism. Participants indicated that they were not concerned 
about side-effects such as dizziness, nausea, pain and swelling at the injection site, or 
fainting. 
P: No, those [dizziness, nausea, pain and swelling at the injection site, or fainting] 
could be like remedied. Because sometimes, while a young girl menstrual, she’ll 
experience stuff like that. So that’s minor, minor. Bigger issues are, you know, how 
it will affect her mentally and physically and, you know, skin irritation [skin breaks 
out in blotches] and you know, if she had swelling of the limbs and things like that.
P: If there is a 50/50 chance that it [HPV] would leave my child handicapped or 
something, that would turn me off.
P: Probably anything that would adversely affect her female organs, her reproductive 
organs, you know, or would cause damage to her like immune system or something 
like that.
P: My concern was would it make her menstruation act crazy, would she gain weight 
or change her eating habits, you know, would it affect her physical health. That was 
my concern.
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One parent was very knowledgeable about the vaccine and discussed HPV vaccine 
safety in terms of a false sense of safety. She noted that the HPV vaccine did not protect 
against all strains of the virus and might lead youth to forget the health risks associated 
with strains that were not protected against. 
Males were more likely to express concerns about the government’s role in the devel-
opment of the HPV vaccine and vaccination efforts and their implications for HPV 
vaccine safety. Several men made comments such as, “Tuskegee has to be considered.” 
Female participants expressed varied views, from dismissal of concerns related to 
experimentation to the importance of participating in vaccine and other research in 
order to improve community health. 
P: No, they experiment on everybody. I mean, how do they think, the people will have 
to experiment to know what’s good. I mean, they experiment on animals. Animals is 
animals, humans is humans, okay, so if they experiment on people that’s your deci-
sion if you want them to experiment and for you to get help. I mean, they tell you 
when you get it, it’s a risk. 
P: They experiment on everybody with it though. It’s not necessarily just Black people.
Youth sexuality. Parents noted that they would see more urgency to HPV vaccina-
tion if they believed that their daughters were sexually active; however, sexuality was 
not the primary basis for making the HPV decision. Parents reported that the health 
of the child was the main factor in their HPV vaccination decision. 
P: I explained to my daughter, it’s not about trying to have sex or be grown. It’s about 
your health, what’s important for you. It’s about cancer.
Parents also commented that they did not believe that HPV vaccination would encourage 
early sexuality. One parent stated, “The shot [is] not a hormone shot; it will not make 
them want to have sex.” Parents did discuss that adolescents might not understand 
that they were only being protected against cervical cancer. This lack of understanding 
was discussed in relationship to sexual risk taking among vaccinated youth. However, 
parents indicated that youth engaging in risky sexual behavior were likely to do so 
regardless of HPV vaccination status, and that this was an issue of parent child com-
munication and supervision.
P: Getting them the vaccination, no, that’s not a sign. Now putting them on birth 
control, that’s a sign of permission. 
P: I guide them, even my son. You know, I talk about abstinence all the time. So guide 
them. After they graduate and get out of my household, that’s fine. But while they’re 
here, no. I know they’re young, and I know they’re human and things come up. But, 
I don’t think it really give them permission to have sex. 
The age of the child was discussed as a part of concerns about sexuality. Parents expressed 
reluctance to vaccinate girls as young as nine years old. Parents stated that they were less 
concerned about sexuality at this age, which was believed to inform risk of infection. 
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Parents reported that they had time to protect their daughter’s health. Most expressed 
a preference that HPV vaccination not be discussed before age 12.
Vaccine costs. When costs and religious issues were not discussed, participants were 
queried about these issues. Parents indicated that private insurance or Medicaid coverage 
made vaccination feasible given the cost of the series of shots. Among those parents 
who were unaware that HPV vaccination involved three shots, costs were not viewed 
as a barrier. Among parents who were unaware of the HPV vaccine associated costs, 
the researchers provided this information to gain insight into how this knowledge of 
HPV vaccine related costs would affect their attitudes about HPV vaccination. Many 
parents were shocked at the costs and this led to more extensive discussions of this 
issue. Those with insurance were less concerned, but indicated that coverage by their 
insurer would determine whether the vaccination was provided. Uninsured parents 
expressed caution toward HPV vaccine uptake. They discussed the need to ensure that 
they would not incur medical bills that they were unable to pay.
P: It’s only going to affect my decision to a point; if it’s something that I deem neces-
sary or we (husband) deem necessary, then it’s going to happen.
P: I mean as long as it’s within reason and it’s something that I feel I could pay for and 
afford, then no cost would not affect my decision. If it’s not like an outrageous price.
HPV vaccine and religious issues. Religious concerns were discussed when the 
researchers asked about them, but participants did not believe that the issue affected 
their decisions about their own child(ren). Participants who expressed a devout com-
mitment to their religious beliefs stated that they would pray for guidance, but many 
indicated that church leaders and doctrine could not decide the issue of HPV vaccination.
P: Yeah, yes, I did. I always trust God first. I always pray for guidance and protection. 
And if it’s something He put on this earth to help His people, then yes, you know, I 
want that to be given to my daughter. I’m led by the Holy Spirit. It led me to make 
the right decision that this would help her, you know, then yeah. 
One participant noted the importance of a “spirit of discernment,” in which religious 
beliefs, prayer and spiritual guidance are used to make individual decisions. 
P: God has his place because—and that is at the head, but there are certain decisions, 
you know he gives you the spirit of discernment too. So there are decisions that you 
are gonna have to make whether he is involved in it or not. 
Participants speculated that parents from some religious denominations, such as Jeho-
vah’s Witness, might have stronger objections. There was also discussion of whether 
older members of the church could be relied upon for advice and guidance as new 
health issues and treatments emerged because of their tie to old-fashioned beliefs.
P: I could talk to my mother about it, but that would not go into my decision mak-
ing process. Not that I don’t trust my mother’s opinion, but she knows less than I 
do about it. 
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Discussion
This paper adds to the literature on African American HPV vaccination attitudes and 
presents data using a sample from the U.S. Midwest. African American parental inter-
views suggest confidence in the ability to obtain HPV vaccination for their age eligible 
daughters. Although parents in this sample expressed confidence, they admitted that 
they sometimes lacked necessary HPV knowledge and often relied on their physicians 
for information to fill this knowledge gap. While many participants were religious, 
religion did not appear to be a barrier to HPV vaccination and these parents dismissed 
concerns that HPV vaccination would result in early or promiscuous sex. There were 
however concerns about and a desire for information related to HPV vaccine safety 
and costs, as well as age of vaccination.
Consistent with the literature,8–10 the strong role that physician recommendation plays 
in African American parents’ intention to obtain HPV vaccination for their daughters 
was noted. Parental discussions of HPV decision-making for their daughters suggest 
that physician recommendations are likely to be followed in the context of an established 
patient-provider relationship. Physicians were also seen as a source of information in 
the absence of knowledge. As other researchers have noted,11,15 there were a number 
of concerns related to vaccine safety, but these did not generally seem to be reflective 
of medical mistrust. Parents noted that they had not heard or found much informa-
tion on serious side effects (changes in menstruation, reproductive ability, or overall 
health) from the vaccine. It appears that serious side effects would affect HPV vaccina-
tion intent more than more immediate side effects (pain, swelling at vaccination site, 
fainting) most often described. Fathers expressed some mistrust of the vaccine based 
on the government’s role in its development, but deferred decisions about vaccination 
to mothers, most of whom rejected these concerns. 
Contrary to previous findings,13,16 parents in this sample did not express concerns 
that HPV vaccination would lead to early or increased youth sexuality. There were 
concerns about vaccinating very young girls because they were perceived as less likely 
to be sexually active. This view suggests that parents are not aware of the reasons for 
the targeted ages for HPV vaccination, which is consistent with the findings of previ-
ous studies.11–15 This suggests an opportunity for education; parents should be helped 
to understand that the goal is to vaccinate girls before they become sexually active in 
order to increase the likelihood of vaccine efficacy. The attitudes related to religion and 
religious beliefs were also somewhat different from those of previous studies.13,16 While 
religion and religious attitudes were important to parents in this sample, they would 
not interfere with decisions made about their children’s health. Parents were confident 
in their ability to use prayer and personal guidance from God to make health deci-
sions and expressed less reliance on church leadership. Parents reported an awareness 
of sexual attitudes and beliefs within the community, church, and family that would 
suggest negatives attitudes toward HPV vaccination, but contrary to earlier studies, 
these attitudes were not prevalent among parents in our sample. 
Most parents interviewed reported that they could overcome barriers to vaccination, 
which have previously been associated with low vaccination rates. However, consistent 
with previous studies,10 parents indicated that insurance coverage and reasonable costs 
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were factors that they had to consider. Parental concerns related to costs suggest an 
opportunity for education. The costs for the vaccine and lack of insurance should not 
represent a barrier because HPV vaccination is covered under the Vaccine for Chil-
dren program. If this information were readily available to uninsured parents it might 
increase vaccination by allaying fears related to costs.
implications. The addition of findings from a Midwest sample to the literature may 
provide information that can inform educational campaigns to assist African American 
parents to make informed decisions about HPV vaccination. New educational mate-
rials will be most useful to African American parents if they discuss both short and 
long-term side effects of HPV vaccination, while also examining their seriousness. 
Health promotion and education materials should include the most recent and accu-
rate information on the side effect profile of the HPV vaccines now available. Parents 
should also be informed of the Vaccine for Children program that can assist with the 
costs of obtaining the HPV vaccination series. A new tool might also assist parents 
by allowing them to weigh the side effects, benefits, costs, and any other individual, 
social, or cultural concerns they might have to make the best decision for their child 
and family circumstance. This suggests that some parents might find a decision tool 
helpful. However, the most important activity will be working with the health care com-
munity to assure that African American parents and their age eligible children have an 
opportunity to discuss sexual behavior and sexually transmitted infections, including 
HPV, with their providers to facilitate informed decision-making and action, using 
their preferred source of information and consultation. This focus on the health care 
community should also include linking African American parents and their children 
to health care resources. An emphasis should be placed on ensuring the establishment 
of good patient-provider relationships so that the appropriate discussions take place. 
limitations. Researchers and health educators should carefully consider the limita-
tions of these interviews when considering their utility in other settings and populations. 
It is possible that the lack of diversity among survey administrators and interviewers 
augmented the responses of study participants producing socially desirable comments. 
Although an effort was made to include African Americans of diverse backgrounds, the 
participants were not representative of a national or local sample of African Americans. 
Therefore, there may be greater numbers of individuals with health care and physician 
relationships in this sample, which may limit the generalizability of our findings. This 
sample consisted of volunteers, and it is impossible to know how individuals who chose 
to participate differ from those who did not; refusal rates and data on those refusing 
were not collected. Finally, these interviews were completed before the approval of 
Cervarix and before Gardasil was approved for men and only parents of girls were 
interviewed and parental comments were focused on what they knew about Gardasil. 
Conclusion. The findings of the current study suggest that African American 
parents, in consultation with trusted health care providers, expect to exercise strong 
influence over HPV vaccination of their daughters. While larger, long-term studies of 
HPV vaccination attitude, intent, and behavior are needed, this study suggests HPV 
and HPV vaccination information needs can be addressed through these health care 
relationships and in targeted educational materials and decision tools.
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